ProShare Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$211K Sell
28,809
-1,232
-4% -$9.01K ﹤0.01% 1693
2025
Q1
$285K Sell
30,041
-8,404
-22% -$79.8K ﹤0.01% 1448
2024
Q4
$634K Buy
38,445
+11,831
+44% +$195K ﹤0.01% 1139
2024
Q3
$393K Buy
26,614
+6,995
+36% +$103K ﹤0.01% 1288
2024
Q2
$272K Sell
19,619
-6,064
-24% -$84.1K ﹤0.01% 1354
2024
Q1
$404K Buy
25,683
+1,765
+7% +$27.7K ﹤0.01% 1224
2023
Q4
$387K Buy
23,918
+4,526
+23% +$73.2K ﹤0.01% 1210
2023
Q3
$239K Sell
19,392
-513
-3% -$6.31K ﹤0.01% 1355
2023
Q2
$320K Buy
19,905
+1,644
+9% +$26.4K ﹤0.01% 1237
2023
Q1
$318K Sell
18,261
-1,618
-8% -$28.2K ﹤0.01% 1180
2022
Q4
$184K Buy
19,879
+2,579
+15% +$23.8K ﹤0.01% 1519
2022
Q3
$149K Sell
17,300
-2,270
-12% -$19.6K ﹤0.01% 1468
2022
Q2
$159K Sell
19,570
-8,797
-31% -$71.5K ﹤0.01% 1527
2022
Q1
$344K Sell
28,367
-3,356
-11% -$40.7K ﹤0.01% 1530
2021
Q4
$1.08M Buy
31,723
+11,114
+54% +$379K ﹤0.01% 977
2021
Q3
$994K Sell
20,609
-12,013
-37% -$579K ﹤0.01% 915
2021
Q2
$1.47M Buy
32,622
+133
+0.4% +$6.01K ﹤0.01% 836
2021
Q1
$1.57M Buy
32,489
+7,144
+28% +$345K ﹤0.01% 779
2020
Q4
$1.37M Buy
25,345
+10,650
+72% +$574K 0.01% 755
2020
Q3
$542K Sell
14,695
-1,225
-8% -$45.2K ﹤0.01% 911
2020
Q2
$493K Buy
15,920
+8,654
+119% +$268K ﹤0.01% 952
2020
Q1
$201K Sell
7,266
-8,528
-54% -$236K ﹤0.01% 1012
2019
Q4
$462K Buy
15,794
+2,305
+17% +$67.4K ﹤0.01% 1105
2019
Q3
$258K Buy
13,489
+1,858
+16% +$35.5K ﹤0.01% 1303
2019
Q2
$255K Sell
11,631
-14
-0.1% -$307 ﹤0.01% 1322
2019
Q1
$238K Buy
+11,645
New +$238K ﹤0.01% 1369
2014
Q2
Sell
-33,300
Closed -$116K 2552
2014
Q1
$116K Buy
+33,300
New +$116K ﹤0.01% 2669
2013
Q4
Sell
-20,773
Closed -$62K 1675
2013
Q3
$62K Buy
+20,773
New +$62K ﹤0.01% 2490